Transcatheter aortic valve implantation (TAVI) in Istanbul typically costs from $19,000 to $25,300. The final price depends on the specific valve brand, the surgical approach, and the hospital's accreditation level. Patients save around 65% compared to the US, where this procedure costs $63,000 on average. Most Istanbul packages include preoperative tests, cardiology consultations, hospitalization, and airport-clinic transfers.
Bookimed Expert Insight: Istanbul is Turkey's primary hub for complex cardiovascular care, housing the highest concentration of JCI-accredited facilities. The city offers a unique value where university-level expertise meets advanced technology, such as the 640-slice CT scanners at Hisar Hospital. Clinics like Medipol Mega routinely perform TAVI without open surgery, providing a high-volume environment that often ensures better cost-efficiency for international patients than regional centers.
| Istanbul | Austria | Spain | |
| Transcatheter aortic valve implantation (TAVI) | from $19,000 | ≈ $28,000 | ≈ $30,000 |
Day 1
Day 2
Day 3
Day 4
Day 5-7
Week 2
Week 3-6
Week 7
Week 8-12
Please note that this timeline may vary based on individual patient needs and recovery rates.
Dr. Ibrahim Halil Tanboga is an interventional cardiologist at Hisar Hospital Intercontinental in Istanbul. He specializes in heart valve diseases and congenital structural heart conditions. Dr. Tanboga conducted specialized heart valve research at St. Thomas Hospital in London. He holds a PhD in Biostatistics.
Dr. Servet Izci is a cardiologist with 24 years of clinical practice. He earned his MD at Fırat University (1996–2002). He completed a cardiology residency at Kartal Koşuyolu Training and Research Hospital (2010–2015). He worked as a consultant cardiologist at Kartal Koşuyolu (2015–2025) and Pendik Medical Park (2025–2026). He now practices at Lokman Hekim Istanbul Hospital (2026–present). He is a member of the Istanbul Medical Chamber and the Turkish Society of Cardiology.
Clinical focus: coronary angiography and stenting via radial access. He also performs peripheral and carotid artery interventions. He manages arrhythmias, hypertension, hyperlipidemia, and heart failure. Scientific output: three publications. Topics include catestatin as a predictor of mortality in acute pulmonary embolism, ECG changes during alcohol withdrawal, and the increased risk of high‑grade AV block in non‑O blood types.
Dr. Fatih Mehmet Ucar is an interventional cardiologist at Istanbul Florence Nightingale Hospital. He specializes in electrophysiology and arrhythmia treatment. Dr. Ucar completed residency training at the Cleveland Clinic in the United States. He also underwent electrophysiology training at Lübeck Hospital in Germany.
Performs TAVI procedures at Istanbul Florence Nightingale Hospital – trained at Toronto General Hospital and Koşuyolu Heart Training and Research Hospital.